Search for Clinical Trial Results

Sponsored By

PASLI Disease - 2 Studies Found

Status Study
Recruiting Study Name: Extension to the Study of Efficacy of CDZ173 in Patients With APDS/PASLI
Condition: Activated PI3Kdelta Syndrome (APDS); PASLI Disease
Date: 2016-08-04
Interventions: Drug: CDZ173 140 mg/day
Recruiting Study Name: Safety, Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Repeat Doses of Inhaled GSK2269557 in Patients With APDS/PASLI
Condition: Activated PI3K-delta Syndrome
Date: 2015-10-29
Interventions: Drug: GSK2269557 DPI 500 mcg Subjects will receive 2 inhalations of GSK2269557 500 mcg in DPI (total dos